Pseudomonas aeruginosa AmpR: An acute-chronic switch regulator

Pathogens and Disease

Volumn 73, Issue 2, 2014, Pages

  Balasubramanian, Deepak ^a   Kumari, Hansi ^b   Mathee, Kalai ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; C di GMP; Global regulator; Pseudomonas aeruginosa virulence; Quorum sensing; Ser thr protein phosphorylation

Indexed keywords

BACTERIAL PROTEIN; PROTEIN AMPR; UNCLASSIFIED DRUG; AMPR PROTEIN, BACTERIA;

ANTIBIOTIC RESISTANCE; BACTERIAL METABOLISM; CELLULAR STRESS RESPONSE; CROSS RESISTANCE; ENTEROBACTERIACEAE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PHYSIOLOGY; REGULON;

BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GENE REGULATORY NETWORKS; PSEUDOMONAS AERUGINOSA; REGULON;

EID: 84913573398     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12208     Document Type: Short Survey

References (155)

1. Afessa B, Green W, Chiao J, Frederick W Pulmonary complications of HIV infection: autopsy findings. Chest 1998;113:1225-9.
2. Aliaga L, Mediavilla JD, Cobo F A clinical index predictingmortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 2002;51:615-9.
3. Asgarali A, Stubbs KA, Oliver A, Vocadlo DJ, Mark BL Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:2274-82.
4. Avison MB, Horton RE, Walsh TR, Bennett PM Escherichia coli CreBC is a global regulator of gene expression that responds to growth in minimal media. J Biol Chem 2001;276:26955-61.
5. Avison MB, Niumsup P, Nurmahomed K, Walsh TR, Bennett PM Role of the 'cre/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila beta-lactamase regulator, BlrA. J Antimicrob Chemother 2004;53:197-202.
6. Bagge N, Ciofu O, Hentzer M, Campbell JI, Givskov M, Hoiby N Constitutive high expression of chromosomal betalactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob Agents Chemother 2002;46:3406-11.
7. Balasubramanian D, Kong KF, Jayawardena SR, Leal SM, Sautter RT, Mathee K Co-regulation of (beta)-lactam resistance, alginate production and quorum sensing in Pseudomonas aeruginosa. J Med Microbiol 2011;60:147-56.
8. Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K The regulatory repertoire of Pseudomonas aeruginosa AmpC β-lactamase regulator AmpR includes virulence genes. PLoS ONE 2012;7:e34067.
9. Balasubramanian D, Schneper L, Kumari H, Mathee K A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 2013a;41:1-20.
10. Balasubramanian D, Murugapiran SK, Silva-Herzog E, et al. (2013b) Transcriptional regulatory network in Pseudomonas aeruginosa. Bacterial Gene Regulation and Transcriptional Networks (Madan Babu M, ed), pp. 199-222. Caiser Academic Press, Norfolk, UK.
11. Balasubramanian D, Kumari H, Jaric M, et al. Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response. Nucleic Acids Res 2014;42:979-98.
12. Balcewich MD, Reeve TM, Orlikow EA, Donald LJ, Vocadlo DJ, Mark BL Crystal structure of the AmpR effector binding domain provides insight into the molecular regulation of inducible ampC beta-lactamase. J Mol Biol 2010;400:998-1010.
13. Behrends V, Ryall B, Zlosnik JE, Speert DP, Bundy JG, Williams HD Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol 2013;15:398-408.
14. Bergstrom S, Lindberg FP, Olsson O, Normark S Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other gram-negative bacteria. J Bacteriol 1983;155:1297-1305.
15. Bjarnsholt T, Jensen PO, Fiandaca MJ, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009;44:547-58.
16. Boles BR, Singh PK Endogenous oxidative stress produces diversity and adaptability in biofilm communities. P Natl Acad Sci USA 2008;105:12503-08.
17. Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrob Chemother 1998;42:697-702.
18. Boyd N, Nailor MD Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2011;31:1073-84.
19. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN Emerging infections in burns. Surg Infect 2009;10:389-97.
20. Brencic A, Lory S Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA. Mol Microbiol 2009;72:612-32.
21. Brencic A, McFarland KA, McManus HR, Castang S, Mogno I, Dove SL, Lory S The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol Microbiol 2009;73:434-45.
22. Cabot G, Ocampo-Sosa AA, Dominguez MA, et al. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother 2012;56:6349-57.
23. Caille O, Zincke D, Merighi M, et al. Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR. J Bacteriol 2014 (provisionally accepted).
24. Chen HY, Yuan M, Livermore DM Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol 1995 43: 300-9.
25. Chung JC, Becq J, Fraser L, et al. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol 2012;194:4857-66.
26. Ciofu O, Riis B, Pressler T, Poulsen HE, Hoiby N Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 2005;49:2276-82.
27. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Hoiby N Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weakmutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 2010;156:1108-19.
28. Cohen P The regulation of protein function by multisite phosphorylation-a 25 year update. Trends Biochem Sci 2000;25:596-601.
29. Cole ST, Guest JR Production of a soluble form of fumarate reductase by multiple gene duplication in Escherichia coli K12. Eur J Biochem 1979;102:65-71.
30. Cole ST, Nicolas MH Beta-lactam resistance mechanisms in Gram-negative bacteria. Microbiol Sci 1986;3:334-9.
31. Cramer N, Wiehlmann L, Tummler B Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. Int J Med Microbiol 2010;300:526-33.
32. Davies JC, Rubin BK Emerging and unusual Gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 2007;28:312-21.
33. Deplano A, Denis O, Poirel L, et al. Molecular characterization of an epidemic clone of pan antibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 2005;43:1198-204.
34. Dereeper A, Guignon V, Blanc G, et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 2008;36:W465-9.
35. Dereeper A, Audic S, Claverie JM, Blanc G BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol Biol 2010;10:8.
36. Doggett RG Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Appl Microbiol 1969;18:936-7.
37. Dotsch A, Eckweiler D, Schniederjans M, et al. The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS ONE 2012;7:e31092.
38. Driffield K, Miller K, Bostock JM, O'Neill AJ, Chopra I Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 2008;61:1053-6.
39. Edlund T, Grundstrom T, Normark S Isolation and characterization of DNA repetitions carrying the chromosomal beta-lactamase gene of Escherichia coli K-12. Mol Gen Genet 1979;173:115-25.
40. Feliziani S, Lujan AM, Moyano AJ, et al. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections. PLoS ONE 2010;5:e12669.
41. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Hoiby N, Molin S Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 2012;10:841-51.
42. Foundation Cystic Fibrosis Foundation Patient Registry Annual Data Report 2011Bethesda, MDCystic Fibrosis Foundation.
43. Gomez-Lozano M, Marvig RL, Molin S, Long KS Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa. Environ Microbiol 2012;14:2006-16.
44. Gonzalez N, Heeb S, Valverde C, Kay E, Reimmann C, Junier T, Haas D Genome-wide search reveals a novel GacA-regulated small RNA in Pseudomonas species. BMC Genomics 2008;9:167.
45. Goodman AL, Merighi M, Hyodo M, Ventre I, Filloux A, Lory S Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen. Genes Dev 2009;23:249-59.
46. Gould VC, Okazaki A, Avison MB Beta-lactam resistance and beta-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J Antimicrob Chemother 2006;57:199-203.
47. Grundstrom T, Jaurin B Overlap between ampC and frd operons on the Escherichia coli chromosome. P Natl Acad Sci USA 1982;79:1111-5.
48. Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 2007;39:687-93.
49. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 2010;59:253-68.
50. Hauser AR The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 2009;7:654-65.
51. HengzhuangW, Wu H, Ciofu O, Song Z, Hoiby N Pharmacokinetics/ pharmacodynamics of colistin and imipenem onmucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2011;55:4469-74.
52. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011.
53. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, Miller SI Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 2009;8:66-70.
54. Hogardt M, Heesemann J Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol 2013;358:91-118.
55. Hoiby N Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med 2011;9:32.
56. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35:322-32.
57. Honore N, Nicolas MH, Cole ST Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J 1986;5:3709-14.
58. Horino T, Chiba A, Kawano S, et al. Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa. Intern Med 2012;51:59-64.
59. Hunter T Signaling-2000 and beyond. Cell 2000;100:113-27.
60. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction. EMBO J 1994;13:4684-94.
61. Jacobs C, Frere JM, Normark S Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria. Cell 1997;88:823-32.
62. Jaurin B, Grundstrom T, Normark S Sequence elements determining ampC promoter strength in E. coli. EMBO J 1982;1:875-81.
63. Jimenez PN, Koch G, Thompson JA, Xavier KB, Cool RH, QuaxWJ The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 2012;76:46-65.
64. Johnson SJ, Ernst EJ, Moores KG Is double coverage of Gramnegative organisms necessary? Am J Health Syst Pharm 2011;68:119-24.
65. Juan C, Moya B, Perez JL, Oliver A Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother 2006;50:1780-87.
66. Kannan N, Taylor SS, Zhai Y, Venter JC, Manning G Structural and functional diversity of the microbial kinome. PLoS Biol 2007;5:e17.
67. Kelly-Wintenberg K, South SL, Montie TC Tyrosine phosphate in a-and b-type flagellins of Pseudomonas aeruginosa. J Bacteriol 1993;175:2458-61.
68. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007;130:797-810.
69. Kong KF, Jayawardena SR, Del Puerto A, Wiehlmann L, Laabs U, Tummler B, Mathee K Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase. Gene 2005a;358:82-92.
70. Kong KF, Jayawardena SR, Indulkar SD, Del Puerto A, Koh CL, Hoiby N, Mathee K Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob Agents Chemother 2005b;49:4567-75.
71. Kong KF, Aguila A, Schneper L, Mathee K Pseudomonas aeruginosa beta-lactamase induction requires two permeases, AmpG and AmpP. BMC Microbiol 2010;10: 328.
72. Kuga A, Okamoto R, Inoue M ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae. Antimicrob Agents Chemother 2000;44:561-7.
73. Kulasakara H, Lee V, Brencic A, et al. Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. P Natl Acad Sci USA 2006;103:2839-44.
74. Kumari H, Balasubramanian D, Zincke D, Mathee K Role of Pseudomonas aeruginosa AmpR on beta-lactam and nonbeta-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics. J Med Microbiol 2014a;63:544-55.
75. Kumari H, Murugapiran SK, Balasubramanian D, et al. LTQ-XL mass spectrometry proteome analysis expands the Pseudomonas aeruginosa AmpR regulon to include cyclic di-GMP phosphodiesterases and phosphoproteins, and identifies novel open reading frames. J Proteomics 2014b;96C:328-42.
76. Lapouge K, Schubert M, Allain FH, Haas D Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour. Mol Microbiol 2008;67:241-53.
77. Laskowski MA, Kazmierczak BI Mutational analysis of RetS, an unusual sensor kinase-response regulator hybrid required for Pseudomonas aeruginosa virulence. Infect Immun 2006;74:4462-73.
78. Latifi A, Foglino M, Tanaka K, Williams P, Lazdunski A A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol 1996;21:1137-46.
79. Letunic I, Bork P Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 2007;23:127-8.
80. Letunic I, Bork P Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res 2011;39:W475-8.
81. Lindberg F, Normark S Contribution of chromosomal betalactamases to beta-lactam resistance in enterobacteria. Rev Infect Dis 1986;8(suppl 3)S292-S304.
82. Lindberg F, Normark S Common mechanism of ampC betalactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene. J Bacteriol 1987;169:758-63.
83. Lindberg F, Westman L, Normark S Regulatory components in Citrobacter freundii ampC beta-lactamase induction. P Natl Acad Sci USA 1985;82:4620-24.
84. Lindquist S, Lindberg F, Normark S Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC betalactamase gene. J Bacteriol 1989;171:3746-53.
85. Lister PD, Wolter DJ, Hanson ND Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009;22:582-610.
86. Livermore DM Clinical significance of beta-lactamase induction and stable derepression in Gram-negative rods. Eur J Clin Microbiol 1987;6:439-45.
87. Lodge JM, Minchin SD, Piddock LJ, Busby JW Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC betalactamase. Biochem J 1990;272:627-31.
88. Lodge J, Busby S, Piddock L Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter. FEMS Microbiol Lett 1993;111:315-20.
89. Lopez-Causape C, Rojo-Molinero E, Mulet X, et al. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS ONE 2013;8:e71001.
90. Lyczak JB, Cannon CL, Pier GB Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15:194-222.
91. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 2009;5:e1000354.
92. Macek B, Mijakovic I, Olsen JV, Gnad F, Kumar C, Jensen PR, Mann M The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol Cell Proteomics 2007;6:697-707.
93. Maddocks SE, Oyston PC Structure and function of the LysR-type transcriptional regulator (LTTR) family proteins. Microbiology 2008;154:3609-23.
94. Mahlen SD, Morrow SS, Abdalhamid B, Hanson ND Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J Antimicrob Chemother 2003;51:791-802.
95. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, Deretic V Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. P Natl Acad Sci USA 1993;90:8377-81.
96. Martin LW, Reid DW, Sharples KJ, Lamont IL Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 2011;24:1059-67.
97. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000;44:3322-7.
98. Mathee K, Ciofu O, Sternberg C, et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999;145:1349-57.
99. McGrath S, Wade DS, Pesci EC Dueling quorum sensing systems in Pseudomonas aeruginosa control the production of the Pseudomonas quinolone signal (PQS). FEMS Microbiol Lett 2004;230:27-34.
100. Mesaros N, Nordmann P, Plesiat P, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007;13:560-78.
101. Meyer JM, Neely A, Stintzi A, Georges C, Holder IA Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun 1996;64:518-23.
102. Mougous JD, Gifford CA, Ramsdell TL, Mekalanos JJ Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa. Nat Cell Biol 2007;9:797-803.
103. Moya B, Dotsch A, Juan C, Blazquez J, Zamorano L, Haussler S, Oliver A Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog 2009;5:e1000353.
104. Mulcahy H, O'Callaghan J, O'Grady EP, et al. Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation. Infect Immun 2008;76:632-8.
105. Naas T, Livermore DM, Nordmann P Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing betalactamase Sme-1, and comparison of this regulator with other beta-lactamase regulators. Antimicrob Agents Chemother 1995;39:629-37.
106. Nicolas MH, Honore N, Jarlier V, Philippon A, Cole ST Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob Agents Chemother 1987;31:295-9.
107. Normark S, Edlund T, Grundstrom T, Bergstrom S, Wolf-Watz H Escherichia coli K-12 mutants hyperproducing chromosomal beta-lactamase by gene repetitions. J Bacteriol 1977;132:912-22.
108. Normark S, Lindquist S, Lindberg F Chromosomal betalactam resistance in enterobacteria. Scand J Infect Dis Suppl 1986;49:38-45.
109. Okazaki A, Avison MB Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob Agents Chemother 2008;52:1525-8.
110. Oliver A, Canton R, Campo P, Baquero F, Blazquez J High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000;288:1251-4.
111. Olsson O, Bergstrom S, Normark S Identification of a novel ampC beta-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J 1982;1:1411-6.
112. Papadopoulos JS, Agarwala R COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 2007;23:1073-9.
113. Paul M, Leibovici L Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia. Lancet Infect Dis 2005;5:192-3.
114. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004;328:668.
115. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2006;1:CD003344.
116. Pena C, Suarez C, Gozalo M, et al. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012;56:1265-72.
117. Pendleton JN, Gorman SP, Gilmore BF Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013;11:297-308.
118. Pesci EC, Pearson JP, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1997;179:3127-32.
119. Potvin E, Sanschagrin F, Levesque RC Sigma factors in Pseudomonas aeruginosa. FEMS Microbiol Rev 2008;32:38-55.
120. Proenca R, Niu WW, Cacalano G, Prince A The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases. Antimicrob Agents Chemother 1993;37:667-74.
121. Raso T, Bianco O, Grosso B, Zucca M, Savoia D Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 2008;116:837-41.
122. Rice LB Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol 2010;31:S7-S10.
123. Romling U, Galperin MY, Gomelsky M Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 2013;77:1-52.
124. Ryan RP Cyclic di-GMP signalling and the regulation of bacterial virulence. Microbiology 2013;159:1286-97.
125. Ryan RP, Lucey J, O'Donovan K, McCarthy Y, Yang L, Tolker-Nielsen T, Dow JM HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa. Environ Microbiol 2009;11:1126-36.
126. Schell MA Molecular biology of the LysR family of transcriptional regulators. Annu Rev Microbiol 1993;47:597-626.
127. Schmidtke AJ, Hanson ND Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008;52:3922-7.
128. Schuster M, Greenberg EP A network of networks: quorumsensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol 2006;296:73-81.
129. Schuster M, Hawkins AC, Harwood CS, Greenberg EP The Pseudomonas aeruginosa RpoS regulon and its relationship to quorum sensing. Mol Microbiol 2004;51:973-85.
130. Seoane A, Francia MV, Garcia Lobo JM Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica. Antimicrob Agents Chemother 1992;36:1049-52.
131. Smith EE, Buckley DG, Wu Z, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. P Natl Acad Sci USA 2006;103:8487-92.
132. Sonnleitner E, Abdou L, Haas D Small RNA as global regulator of carbon catabolite repression in Pseudomonas aeruginosa. P Natl Acad Sci USA 2009;106:21866-71.
133. Sonnleitner E, Gonzalez N, Sorger-Domenigg T, et al. The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Mol Microbiol 2011;80:868-85.
134. Sonnleitner E, Romeo A, Blasi U Small regulatory RNAs in Pseudomonas aeruginosa. RNA Biol 2012;9:364-71.
135. Stapper AP, Narasimhan G, Ohman DE, et al. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation. J Med Microbiol 2004;53:679-90.
136. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000;406:959-64.
137. Suarez C, Pena C, Arch O, et al. A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition. BMC Infect Dis 2011;11:272.
138. Suh SJ, Silo-Suh L, Woods DE, Hassett DJ, West SE, Ohman DE Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol 1999;181:3890-97.
139. Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20:1-55.
140. Tamma PD, Cosgrove SE, Maragakis LL Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 2012;25:450-70.
141. Trepanier S, Prince A, Huletsky A Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysRtype transcriptional regulator. Antimicrob Agents Chemother 1997;41:2399-405.
142. Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A The chaperone/ usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. P Natl Acad Sci USA 2001;98:6911-6.
143. Vento S, Cainelli F, Temesgen Z Lung infections after cancer chemotherapy. Lancet Oncol 2008;9:982-92.
144. Ventre I, Goodman AL, Vallet-Gely I, et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. P Natl Acad Sci USA 2006;103:171-6.
145. Venturi V Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev 2006;30:274-91.
146. Weng SF, Lin JW, Chen CH, Chen YY, Tseng YH Constitutive expression of a chromosomal class A (BJM group 2) beta-lactamase in Xanthomonas campestris. Antimicrob Agents Chemother 2004;48:209-15.
147. Wiedenheft B, Sternberg SH, Doudna JA RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012;482:331-8.
148. Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, Vasil ML Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. P Natl Acad Sci USA 2004;101:9792-7.
149. Williams P, Camara M Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 2009;12:182-91.
150. Winsor GL, Lam DK, Fleming L, et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 2011;39:D596-D600.
151. Wong A, Rodrigue N, Kassen R Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet 2012;8:e1002928.
152. Yang L, Jelsbak L, Molin S Microbial ecology and adaptation in cystic fibrosis airways. Environ Microbiol 2011;13:1682-9.
153. Zamorano L, Reeve TM, Deng L, et al. NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010;54:3557-63.
154. Zeng E, Mathee K, Narasimhan G IEM: an algorithm for iterative enhancement of motifs using comparative genomics data. Comput Syst Bioinformatics Conf 2007;6:227-35.
155. Zhang Y, Bao Q, Gagnon LA, Huletsky A, Oliver A, Jin S, Langaee T ampG gene of Pseudomonas aeruginosa and its role in beta-lactamase expression. Antimicrob Agents Chemother 2010;54:4772-9.